Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series) - Image 1

£97.00

CRC Press Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Name: Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 97.0 GBP
Availability: InStock

Pharmacy - Dispensing

This is the usual price. Wait for it to drop, or tell us your number.

£97 today · usual range £0–£0 · best ever £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 639 days • 639 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 639 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £99 (430 days, 67.3%)

Price range: £76 - £115

Price levels: 9 different prices over 639 days

Description

Statistical methods that are commonly used in the review and approval process of regulatory submissions are usually referred to as statistics in regulatory science or regulatory statistics. In a broader sense, statistics in regulatory science can be defined as valid statistics that are employed in the review and approval process of regulatory submissions of pharmaceutical products. In addition, statistics in regulatory science are involved with the development of regulatory policy, guidance, and regulatory critical clinical initiatives related research. This book is devoted to the discussion of statistics in regulatory science for pharmaceutical development. It covers practical issues that are commonly encountered in regulatory science of pharmaceutical research and development including topics related to research activities, review of regulatory submissions, recent critical clinical initiatives, and policy/guidance development in regulatory science. Devoted entirely to discussing statistics in regulatory science for pharmaceutical development. Reviews critical issues (e.g., endpoint/margin selection and complex innovative design such as adaptive trial design) in the pharmaceutical development and regulatory approval process. Clarifies controversial statistical issues (e.g., hypothesis testing versus confidence interval approach, missing data/estimands, multiplicity, and Bayesian design and approach) in review/approval of regulatory submissions. Proposes innovative thinking regarding study designs and statistical methods (e.g., n-of-1 trial design, adaptive trial design, and probability monitoring procedure for sample size) for rare disease drug development. Provides insight regarding current regulatory clinical initiatives (e.g., precision/personalized medicine, biomarker-driven target clinical trials, model informed drug development, big data analytics, and real world data/evidence). This book provides key statistical concepts, innovative designs, and analysis methods that are useful in regulatory science. Also included are some practical, challenging, and controversial issues that are commonly seen in the review and approval process of regulatory submissions. About the author Shein-Chung Chow, Ph.D. is currently a Professor at Duke University School of Medicine, Durham, NC. He was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Cambridge, MA, Executive Director at Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers Squibb, Plainsboro, NJ. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Dr. Chow is Editor-in-Chief of the Journal of Biopharmaceutical Statistics and Biostatistics Book Series, Chapman and Hall/CRC Press, Taylor & Francis, New York. Dr. Chow is the author or co-author of over 300 methodology papers and 30 books.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0367224763
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 07 November 2019
Listed Since: 21 June 2019

Barcode

No barcode data available

CRC Press Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Analytical Similarity Assessment in Biosimilar Product Development

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

Producing High-Quality Figures Using SAS/GRAPH® and ODS Graphics Procedures

Statistical Thinking for Non-Statisticians in Drug Regulation

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

Contemporary Biostatistics with Biopharmaceutical Applications (ICSA Book Series in Statistics)

Topics in Applied Statistics: 2012 Symposium of the International Chinese Statistical Association: 55 (Springer Proceedings in Mathematics & Statistics, 55)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Statistical Design and Analysis in Pharmaceutical Science: Validation, Process Controls, and Stability: 143 (Statistics: Textbooks and Monographs)

Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials (Springer Series in Pharmaceutical Statistics)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Recent Advancements in Microbial Diversity: Macrophages and their Role in Inflammation (Woodhead Publishing Series in Composites Science and Engineering)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Elsevier Progress in Medicinal Chemistry (Volume 59) Book